glycyrrhizic acid has been researched along with Cerebral Ischemia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 11 (91.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdur Rub, R; Ahmad, FJ; Ahmad, N; Ahmad, R; Al-Subaiec, AM; Alam, MA; Ashafaq, M; Sharma, S | 1 |
| Barakat, W; El-Maraghy, NN; Safwet, N; Zakaria, MN | 1 |
| Cai, L; Dong, H; Gong, G; Hu, L; Wu, W; Xiang, L; Yin, L; Yuan, L | 1 |
| Feng, T; Lin, Y; Weng, Z; Wu, Y; Zhang, J; Zhou, T | 1 |
| Akman, T; Aras, AB; Cosar, M; Guven, M; Kalkan, Y; Okuyucu, A; Ozkan, A; Sehitoglu, I; Sen, HM; Silan, C | 1 |
| Chen, L; Chu, K; Huang, M; Li, H; Que, J; Xu, W; Ye, M; Zhang, Y | 1 |
| Guo, J; Yang, CX; Yang, JJ; Yao, Y | 1 |
| Chung, SP; Chung, YE; Kavoussi, A; Kim, CH; Lee, JH; Park, I; Seo, J; Yoon, EJ; You, JS | 1 |
| Gu, L; Krams, S; Lee, J; Luo, Y; Wang, Y; Xiong, X; Zhang, H; Zhao, H; Zhu, S | 1 |
| Han, PL; Jin, Y; Kim, ID; Kim, SW; Lee, HK; Lee, JK; Park, S; Shin, JH | 1 |
| Hou, SZ; Li, Y; Wang, X; Wang, ZY; Xu, Y; Zhu, XL | 1 |
| Hosseinzadeh, H; Nassiri Asl, M; Parvardeh, S | 1 |
12 other study(ies) available for glycyrrhizic acid and Cerebral Ischemia
| Article | Year |
|---|---|
Brain-targeted glycyrrhizic-acid-loaded surface decorated nanoparticles for treatment of cerebral ischaemia and its toxicity assessment.
Topics: Administration, Intranasal; Animals; Brain; Brain Ischemia; Drug Carriers; Drug Liberation; Glycyrrhizic Acid; Goats; Male; Nanoparticles; Rats; Rats, Wistar | 2019 |
Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Behavior, Animal; Benzimidazoles; Biphenyl Compounds; Brain; Brain Ischemia; Cytokines; Down-Regulation; Glycyrrhizic Acid; Infarction, Middle Cerebral Artery; Interferon Regulatory Factor-3; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Neuroprotective Agents; Tetrazoles; Toll-Like Receptor 2; Toll-Like Receptor 4; Transcription Factor RelA | 2014 |
Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats.
Topics: Animals; Antioxidants; Apoptosis; Brain Ischemia; Cerebral Infarction; Glycyrrhizic Acid; HMGB1 Protein; Infarction, Middle Cerebral Artery; Inflammation; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Neuroprotective Agents; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats, Sprague-Dawley; Reperfusion Injury | 2014 |
Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway.
Topics: Animals; Apoptosis; Brain; Brain Ischemia; Disease Models, Animal; Glycyrrhizic Acid; HMGB1 Protein; Infarction, Middle Cerebral Artery; Interleukin-17; Male; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neuroprotective Agents; Random Allocation; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4 | 2014 |
The Neuroprotective Effect of Glycyrrhizic Acid on an Experimental Model of Focal Cerebral Ischemia in Rats.
Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Disease Models, Animal; Glycyrrhizic Acid; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2015 |
Blood-brain barrier permeability of Gualou Guizhi granules and neuroprotective effects in ischemia/reperfusion injury.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Capillary Permeability; Chalcones; Citrulline; Drugs, Chinese Herbal; Glucosides; Glycyrrhizic Acid; Infarction, Middle Cerebral Artery; Male; Monoterpenes; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2015 |
Glycyrrhizic Acid Ameliorates Cognitive Impairment in a Rat Model of Vascular Dementia Associated with Oxidative Damage and Inhibition of Voltage-Gated Sodium Channels.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Brain Ischemia; Cognition Disorders; Dementia, Vascular; Disease Models, Animal; Electric Stimulation; Glycyrrhizic Acid; Hippocampus; In Vitro Techniques; Lipid Peroxidation; Long-Term Potentiation; Male; Malondialdehyde; Maze Learning; Oxidative Stress; Patch-Clamp Techniques; Rats; Rats, Wistar; Superoxide Dismutase; Voltage-Gated Sodium Channels | 2016 |
Hypothermia inhibits the propagation of acute ischemic injury by inhibiting HMGB1.
Topics: Acute Disease; Animals; Antibodies, Neutralizing; Antigens, Nuclear; Brain Infarction; Brain Ischemia; Cytokines; Glycyrrhizic Acid; HMGB1 Protein; Hypothermia, Induced; Infarction, Middle Cerebral Artery; Inflammation Mediators; Injections, Intraventricular; Male; Nerve Tissue Proteins; Rats, Wistar | 2016 |
Glycyrrhizin protects against focal cerebral ischemia via inhibition of T cell activity and HMGB1-mediated mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Brain; Brain Infarction; Brain Ischemia; Cell Proliferation; Concanavalin A; Cytokines; Disease Models, Animal; Gene Expression Regulation; Glycyrrhizic Acid; HMGB1 Protein; Mice; Mice, Inbred C57BL; Mice, SCID; Phosphopyruvate Hydratase; Rats; Rats, Nude; Rats, Sprague-Dawley; T-Lymphocytes | 2016 |
Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Glycyrrhizic Acid; HMGB1 Protein; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Phosphorylation; Primary Cell Culture; Rats; Rats, Sprague-Dawley | 2012 |
Ameliorative effects of diammonium glycyrrhizinate on inflammation in focal cerebral ischemic-reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Glycyrrhizic Acid; Infarction, Middle Cerebral Artery; Inflammation; Male; Mice; Random Allocation; Reperfusion Injury; Treatment Outcome | 2012 |
The effects of carbenoxolone, a semisynthetic derivative of glycyrrhizinic acid, on peripheral and central ischemia-reperfusion injuries in the skeletal muscle and hippocampus of rats.
Topics: Animals; Brain Ischemia; Carbenoxolone; Dose-Response Relationship, Drug; Electromyography; Free Radical Scavengers; Glycyrrhiza; Glycyrrhizic Acid; Hippocampus; Injections, Intraperitoneal; Lipid Peroxidation; Male; Malondialdehyde; Muscle, Skeletal; Phytotherapy; Rats; Reperfusion Injury | 2005 |